Departement
Klinische Forschung
Achtung: Diese Seite kann nur von Administratoren besucht werden, da Sie nicht freigeschalten wurde.
Zurück
Publications Schmidt André

Clinical, Brain, and Multilevel Clustering in Early Psychosis and Affective Stages

Dwyer D.B.; Buciuman M.-O.; Ruef A.; Kambeitz J.; Sen Dong M.; Stinson C.; Kambeitz-Ilankovic L.; Degenhardt F.; Sanfelici R.; Antonucci L.A.; Lalousis P.A.; Wenzel J.; Urquijo-Castro M.F.; Popovic D.; Oeztuerk O.F.; Haas S.S.; Weiske J.; Hauke D.; Neufang S.; Schmidt-Kraepelin C.; Ruhrmann S.; Penzel N.; Lichtenstein T.; Rosen M.; Chisholm K.; Riecher-Rossler A.; Egloff L.; Schmidt A.; Andreou C.; Hietala J.; Schirmer T.; Romer G.; Michel C.; Rossler W.; Maj C.; Borisov O.; Krawitz P.M.; Falkai P.; Pantelis C.; Lencer R.; Bertolino A.; Borgwardt S.; Noethen M.; Brambilla P.; Schultze-Lutter F.; Meisenzahl E.; Wood S.J.; Davatzikos C.; Upthegrove R.; Salokangas R.K.R.; Koutsouleris N.. JAMA Psychiatry. 2022.

Clinical, gut microbial and neural effects of a probiotic add-on therapy in depressed patients: a randomized controlled trial.

Schaub AC; Schneider E; Vazquez-Castellanos JF; Schweinfurth N; Kettelhack C; Doll JPK; Yamanbaeva G; Mählmann L; Brand S; Beglinger C; Borgwardt S; Raes J; Schmidt A; Lang UE. Translational Psychiatry. 2022.

Fecal Microbiota Transplantation (FMT) as an Adjunctive Therapy for Depression-Case Report.

Doll JPK; Vázquez-Castellanos JF; Schaub AC; Schweinfurth N; Kettelhack C; Schneider E; Yamanbaeva G; Mählmann L; Brand S; Beglinger C; Borgwardt S; Raes J; Schmidt A; Lang UE. . 2022.

Neurobiologically Based Stratification of Recent-Onset Depression and Psychosis: Identification of Two Distinct Transdiagnostic Phenotypes

Lalousis P.A.; Schmaal L.; Wood S.J.; Reniers R.L.E.P.; Barnes N.M.; Chisholm K.; Griffiths S.L.; Stainton A.; Wen J.; Hwang G.; Davatzikos C.; Wenzel J.; Kambeitz-Ilankovic L.; Andreou C.; Bonivento C.; Dannlowski U.; Ferro A.; Lichtenstein T.; Riecher-Rossler A.; Romer G.; Rosen M.; Bertolino A.; Borgwardt S.; Brambilla P.; Kambeitz J.; Lencer R.; Pantelis C.; Ruhrmann S.; Salokangas R.K.R.; Schultze-Lutter F.; Schmidt A.; Meisenzahl E.; Koutsouleris N.; Dwyer D.; Upthegrove R.. Biological Psychiatry. 2022.

Association of Structural Magnetic Resonance Imaging Measures with Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group Mega-analysis

Jalbrzikowski M.; Hayes R.A.; Wood S.J.; Nordholm D.; Zhou J.H.; Fusar-Poli P.; Uhlhaas P.J.; Takahashi T.; Sugranyes G.; Kwak Y.B.; Mathalon D.H.; Katagiri N.; Hooker C.I.; Smigielski L.; Colibazzi T.; Via E.; Tang J.; Koike S.; Rasser P.E.; Michel C.; Lebedeva I.; Hegelstad W.T.V.; De La Fuente-Sandoval C.; Waltz J.A.; Mizrahi R.; Corcoran C.M.; Resch F.; Tamnes C.K.; Haas S.S.; Lemmers-Jansen I.L.J.; Agartz I.; Allen P.; Amminger G.P.; Andreassen O.A.; Atkinson K.; Bachman P.; Baeza I.; Baldwin H.; Bartholomeusz C.F.; Borgwardt S.; Catalano S.; Chee M.W.L.; Chen X.; Cho K.I.K.; Cooper R.E.; Cropley V.L.; Dolz M.; Ebdrup B.H.; Fortea A.; Glenthoj L.B.; Glenthoj B.Y.; De Haan L.; Hamilton H.K.; Harris M.A.; Haut K.M.; He Y.; Heekeren K.; Heinz A.; Hubl D.; Hwang W.J.; Kaess M.; Kasai K.; Kim M.; Kindler J.; Klaunig M.J.; Koppel A.; Kristensen T.D.; Kwon J.S.; Lawrie S.M.; Lee J.; Leon-Ortiz P.; Lin A.; Loewy R.L.; Ma X.; McGorry P.; McGuire P.; Mizuno M.; Moller P.; Moncada-Habib T.; Munoz-Samons D.; Nelson B.; Nemoto T.; Nordentoft M.; Omelchenko M.A.; Oppedal K.; Ouyang L.; Pantelis C.; Pariente J.C.; Raghava J.M.; Reyes-Madrigal F.; Roach B.J.; Rossberg J.I.; Rossler W.; Salisbury D.F.; Sasabayashi D.; Schall U.; Schiffman J.; Schlagenhauf F.; Schmidt A.; Sorensen M.E.; Suzuki M.; Theodoridou A.; Tomyshev A.S.; Tor J.; Vaernes T.G.; Velakoulis D.; Venegoni G.D.; Vinogradov S.; Wenneberg C.; Westlye L.T.; Yamasue H.; Yuan L.; Yung A.R.; Van Amelsvoort T.A.M.J.; Turner J.A.; Van Erp T.G.M.; Thompson P.M.; Hernaus D.. JAMA Psychiatry. 2021.

Brain volume changes after long-term injectable opioid treatment: A longitudinal voxel-based morphometry study

Schmidt A.; Vogel M.; Baumgartner S.; Wiesbeck G.A.; Lang U.; Borgwardt S.; Walter M.. Addiction biology. 2021.

Classification of first-episode psychosis using cortical thickness: A large multicenter MRI study

Pigoni A.; Dwyer D.; Squarcina L.; Borgwardt S.; Crespo-Facorro B.; Dazzan P.; Smesny S.; Spaniel F.; Spalletta G.; Sanfelici R.; Antonucci L.A.; Reuf A.; Oeztuerk O.F.; Schmidt A.; Ciufolini S.; Schonborn-Harrisberger F.; Langbein K.; Gussew A.; Reichenbach J.R.; Zaytseva Y.; Piras F.; Delvecchio G.; Bellani M.; Ruggeri M.; Lasalvia A.; Tordesillas-Gutierrez D.; Ortiz V.; Murray R.M.; Reis-Marques T.; Di Forti M.; Koutsouleris N.; Brambilla P.. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. 2021.

Functional brain network dysfunctions in subjects at high-risk for psychosis: A meta-analysis of resting-state functional connectivity

Del Fabro L.; Schmidt A.; Fortea L.; Delvecchio G.; D'Agostino A.; Radua J.; Borgwardt S.; Brambilla P.. Neuroscience and biobehavioral reviews. 2021.

Heterogeneity and Classification of Recent Onset Psychosis and Depression: A Multimodal Machine Learning Approach.

Lalousis PA; Wood SJ; Schmaal L; Chisholm K; Griffiths SL; Reniers RLEP; Bertolino A; Borgwardt S; Brambilla P; Kambeitz J; Lencer R; Pantelis C; Ruhrmann S; Salokangas RKR; Schultze-Lutter F; Bonivento C; Dwyer D; Ferro A; Haidl T; Rosen M; Schmidt A; Meisenzahl E; Koutsouleris N; Upthegrove R; PRONIA Consortium.. Schizophrenia bulletin. 2021.

Individuals at Risk of Exercise Addiction Have Higher Scores for Depression, ADHD, and Childhood Trauma.

Colledge F; Buchner U; Schmidt A; Wiesbeck G; Lang U; Pühse U; Gerber M; Walter M. Frontiers in Sports and Active Living. 2021.

Mental Disorders in Individuals With Exercise Addiction-A Cross-Sectional Study.

Meyer M; Sattler I; Schilling H; Lang UE; Schmidt A; Colledge F; Walter M. Frontiers in psychiatry. 2021.

Multimodal Machine Learning Workflows for Prediction of Psychosis in Patients With Clinical High-Risk Syndromes and Recent-Onset Depression.

Koutsouleris N; Dwyer DB; Degenhardt F; Maj C; Urquijo-Castro MF; Sanfelici R; Popovic D; Oeztuerk O; Haas SS; Weiske J; Ruef A; Kambeitz-Ilankovic L; Antonucci LA; Neufang S; Schmidt-Kraepelin C; Ruhrmann S; Penzel N; Kambeitz J; Haidl TK; Rosen M; Chisholm K; Riecher-Rössler A; Egloff L; Schmidt A; Andreou C; Hietala J; Schirmer T; Romer G; Walger P; Franscini M; Traber-Walker N; Schimmelmann BG; Flückiger R; Michel C; Rössler W; Borisov O; Krawitz PM; Heekeren K; Buechler R; Pantelis C; Falkai P; Salokangas RKR; Lencer R; Bertolino A; Borgwardt S; Noethen M; Brambilla P; Wood SJ; Upthegrove R; Schultze-Lutter F; Theodoridou A; Meisenzahl E; PRONIA Consortium. JAMA Psychiatry. 2021.

Multimodal prognosis of negative symptom severity in individuals at increased risk of developing psychosis.

Hauke DJ; Schmidt A; Studerus E; Andreou C; Riecher-Rössler A; Radua J; Kambeitz J; Ruef A; Dwyer DB; Kambeitz-Ilankovic L; Lichtenstein T; Sanfelici R; Penzel N; Haas SS; Antonucci LA; Lalousis PA; Chisholm K; Schultze-Lutter F; Ruhrmann S; Hietala J; Brambilla P; Koutsouleris N; Meisenzahl E; Pantelis C; Rosen M; Salokangas RKR; Upthegrove R; Wood SJ; Borgwardt S; PRONIA Group. Translational Psychiatry. 2021.

Neural mapping of anhedonia across psychiatric diagnoses: A transdiagnostic neuroimaging analysis.

Schaub AC; Kirschner M; Schweinfurth N; Mählmann L; Kettelhack C; Engeli EE; Doll JPK; Borgwardt S; Lang UE; Kaiser S; Walter M; Herdener M; Wrege J; Schmidt A. NeuroImage. Clinical. 2021.

Orbitofrontal-Striatal Structural Alterations Linked to Negative Symptoms at Different Stages of the Schizophrenia Spectrum.

Kirschner M; Schmidt A; Hodzic-Santor B; Burrer A; Manoliu A; Zeighami Y; Yau Y; Abbasi N; Maatz A; Habermeyer B; Abivardi A; Avram M; Brandl F; Sorg C; Homan P; Riecher-Rössler A; Borgwardt S; Seifritz E; Dagher A; Kaiser S. Schizophrenia bulletin. 2021.

Personalized Estimates of Brain Structural Variability in Individuals with Early Psychosis

Antoniades M.; Haas S.S.; Modabbernia A.; Bykowsky O.; Frangou S.; Borgwardt S.; Schmidt A.. Schizophrenia bulletin. 2021.

Psychotic disorders, dopaminergic agents and EEG/MEG resting-state functional connectivity: A systematic review.

Mackintosh AJ; de Bock R; Lim Z; Trulley VN; Schmidt A; Borgwardt S; Andreou C. Neuroscience and biobehavioral reviews. 2021.

Acute oxytocin effects in inferring others’ beliefs and social emotions in people at clinical high risk for psychosis

Schmidt A.; Davies C.; Paloyelis Y.; Meyer N.; De Micheli A.; Ramella-Cravaro V.; Provenzani U.; Aoki Y.; Rutigliano G.; Cappucciati M.; Oliver D.; Murguia S.; Zelaya F.; Allen P.; Shergill S.; Morrison P.; Williams S.; Taylor D.; Borgwardt S.; Yamasue H.; McGuire P.; Fusar-Poli P.. Translational Psychiatry. 2020.

Anatomical integrity within the inferior fronto-occipital fasciculus and semantic processing deficits in schizophrenia spectrum disorders.

Surbeck W; Hänggi J; Scholtes F; Viher PV; Schmidt A; Stegmayer K; Studerus E; Lang UE; Riecher-Rössler A; Strik W; Seifritz E; Borgwardt S; Quednow BB; Walther S. Schizophrenia Research. 2020.

Excessive Exercise-A Meta-Review.

Colledge F; Cody R; Buchner UG; Schmidt A; Pühse U; Gerber M; Wiesbeck G; Lang UE; Walter M. Frontiers in psychiatry. 2020.

Implementing MR Imaging into Clinical Routine Screening in Patients with Psychosis?

Schmidt A; Borgwardt S. NEUROIMAGING CLINICS OF NORTH AMERICA. 2020.

Ketamine Affects Prediction Errors about Statistical Regularities: A Computational Single-Trial Analysis of the Mismatch Negativity.

Weber LA; Diaconescu AO; Mathys C; Schmidt A; Kometer M; Vollenweider F; Stephan KE. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2020.

The genetic architecture of human brainstem structures and their involvement in common brain disorders.

Elvsåshagen T; Bahrami S; van der Meer D; Agartz I; Alnæs D; Barch DM; Baur-Streubel R; Bertolino A; Beyer MK; Blasi G; Borgwardt S; Boye B; Buitelaar J; Bøen E; Celius EG; Cervenka S; Conzelmann A; Coynel D; Di Carlo P; Djurovic S; Eisenacher S; Espeseth T; Fatouros-Bergman H; Flyckt L; Franke B; Frei O; Gelao B; Harbo HF; Hartman CA; Håberg A; Heslenfeld D; Hoekstra PJ; Høgestøl EA; Jonassen R; Jönsson EG; Karolinska Schizophrenia Project (KaSP) consortium; Kirsch P; Kłoszewska I; Lagerberg TV; Landrø NI; Le Hellard S; Lesch KP; Maglanoc LA; Malt UF; Mecocci P; Melle I; Meyer-Lindenberg A; Moberget T; Nordvik JE; Nyberg L; Connell KSO; Oosterlaan J; Papalino M; Papassotiropoulos A; Pauli P; Pergola G; Persson K; de Quervain D; Reif A; Rokicki J; van Rooij D; Shadrin AA; Schmidt A; Schwarz E; Selbæk G; Soininen H; Sowa P; Steen VM; Tsolaki M; Vellas B; Wang L; Westman E; Ziegler GC; Zink M; Andreassen OA; Westlye LT; Kaufmann T. Nature Communications. 2020.

Association of antidepressants with brain morphology in early stages of psychosis: an imaging genomics approach.

Bykowsky O; Harrisberger F; Schmidt A; Smieskova R; Hauke DJ; Egloff L; Riecher-Rössler A; Fusar-Poli P; Huber CG; Lang UE; Andreou C; Borgwardt S. Scientific Reports. 2019.

Cross-Validation of Paranoid-Depressive Scale and Functional MRI: New Paradigm for Neuroscience Informed Clinical Psychopathology.

Stoyanov D; Kandilarova S; Arabadzhiev Z; Paunova R; Schmidt A; Borgwardt S. Frontiers in psychiatry. 2019.

Negative affect moderates the effect of social rejection on frontal and anterior cingulate cortex activation in borderline personality disorder.

Wrege JS; Ruocco AC; Euler S; Preller KH; Busmann M; Meya L; Schmidt A; Lang UE; Borgwardt S; Walter M. Cognitive, affective & behavioral neuroscience. 2019.

No associations between medial temporal lobe volumes and verbal learning/memory in emerging psychosis.

Egloff L; Lenz C; Studerus E; Heitz U; Harrisberger F; Smieskova R; Schmidt A; Leanza L; Andreou C; Borgwardt S; Riecher-Rössler A. The European journal of neuroscience. 2019.

Subtle white matter alterations in schizophrenia identified with a new measure of fiber density.

Stämpfli P; Sommer S; Manoliu A; Burrer A; Schmidt A; Herdener M; Seifritz E; Kaiser S; Kirschner M. Scientific Reports. 2019.

Acute Effects of Glucose and Fructose Administration on the Neural Correlates of Cognitive Functioning in Healthy Subjects: A Pilot Study.

Zanchi D; Meyer-Gerspach AC; Schmidt A; Suenderhauf C; Depoorter A; Drewe J; Beglinger C; Wölnerhanssen BK; Borgwardt S. Frontiers in psychiatry. 2018.

Acute Effects of Methylphenidate, Modafinil, and MDMA on Negative Emotion Processing.

Schmidt A; Müller F; Dolder PC; Schmid Y; Zanchi D; Egloff L; Liechti ME; Borgwardt S. The international journal of neuropsychopharmacology. 2018.

Acute LSD effects on response inhibition neural networks

Schmidt A.; Muller F.; Lenz C.; Dolder P.C.; Schmid Y.; Zanchi D.; Lang U.E.; Liechti M.E.; Borgwardt S.. Psychological medicine. 2018.

Altered network hub connectivity after acute LSD administration

Muller F.; Dolder P.C.; Schmidt A.; Liechti M.E.; Borgwardt S.. NeuroImage-Clinical. 2018.

Disorganized gyrification network properties during the transition to psychosis

Das T.; Borgwardt S.; Hauke D.J.; Harrisberger F.; Lang U.E.; Riecher-Rossler A.; Palaniyappan L.; Schmidt A.. JAMA Psychiatry. 2018.

Potential Mechanisms for the Ketamine-Induced Reduction of P3b Amplitudes.

Rosburg T; Schmidt A. Frontiers in Behavioral Neuroscience. 2018.

Prediction Models of Functional Outcomes for Individuals in the Clinical High-Risk State for Psychosis or with Recent-Onset Depression: A Multimodal, Multisite Machine Learning Analysis

Koutsouleris N.; Kambeitz-Ilankovic L.; Ruhrmann S.; Rosen M.; Ruef A.; Dwyer D.B.; Paolini M.; Chisholm K.; Kambeitz J.; Haidl T.; Schmidt A.; Gillam J.; Schultze-Lutter F.; Falkai P.; Reiser M.; Riecher-Rossler A.; Upthegrove R.; Hietala J.; Salokangas R.K.R.; Pantelis C.; Meisenzahl E.; Wood S.J.; Beque D.; Brambilla P.; Borgwardt S.. JAMA Psychiatry. 2018.

Sexually dimorphic subcortical brain volumes in emerging psychosis

Egloff L.; Lenz C.; Studerus E.; Harrisberger F.; Smieskova R.; Schmidt A.; Huber C.; Simon A.; Lang U.E.; Riecher-Rossler A.; Borgwardt S.. Schizophrenia Research. 2018.

Structural cortical network reorganization associated with early conversion to multiple sclerosis.

Tur C; Eshaghi A; Altmann DR; Jenkins TM; Prados F; Grussu F; Charalambous T; Schmidt A; Ourselin S; Clayden JD; Wheeler-Kingshott CAMG; Thompson AJ; Ciccarelli O; Toosy AT. Scientific Reports. 2018.

Age-related brain structural alterations as an intermediate phenotype of psychosis.

Dukart J; Smieskova R; Harrisberger F; Lenz C; Schmidt A; Walter A; Huber C; Riecher-Rössler A; Simon A; Lang UE; Fusar-Poli P; Borgwardt S. Journal of Psychiatry and Neuroscience. 2017.

Implementing magnetic resonance imaging into clinical routine screening in patients with psychosis?

Borgwardt S.; Schmidt A.. The British journal of psychiatry : the journal of mental science. 2017.

Improving Prognostic Accuracy in Subjects at Clinical High Risk for Psychosis: Systematic Review of Predictive Models and Meta-analytical Sequential Testing Simulation

Schmidt A.; Cappucciati M.; Radua J.; Rutigliano G.; Rocchetti M.; Dell'Osso L.; Politi P.; Borgwardt S.; Reilly T.; Valmaggia L.; McGuire P.; Fusar-Poli P.. Schizophrenia bulletin. 2017.

Increased thalamic resting-state connectivity as a core driver of LSD-induced hallucinations.

Müller F; Lenz C; Dolder P; Lang U; Schmidt A; Liechti M; Borgwardt S. Acta psychiatrica Scandinavica. 2017.

Longitudinal alterations in motivational salience processing in ultra-high-risk subjects for psychosis.

Schmidt A; Antoniades M; Allen P; Egerton A; Chaddock CA; Borgwardt S; Fusar-Poli P; Roiser JP; Howes O; McGuire P. Psychological medicine. 2017.

ABERRANT SALIENCE, HIPPOCAMPAL ACTIVATION, AND SUBCORTICAL DOPAMINE FUNCTION IN PEOPLE AT ULTRA HIGH RISK FOR PSYCHOSIS

SCHMIDT, ANDRE; WINTON-BROWN, TOBY; KAPUR, SHITIJ; ROISER, JON; HOWES, OLIVER; EGERTON, ALICE; GRACE, TONY; STONE, JAMES; MCGUIRE, PHILIP. . 2016.

Altered Insular Function during Aberrant Salience Processing in Relation to the Severity of Psychotic Symptoms.

Walter A; Suenderhauf C; Smieskova R; Lenz C; Harrisberger F; Schmidt A; Vogel T; Lang UE; Riecher-Rössler A; Eckert A; Borgwardt S. Frontiers in psychiatry. 2016.

Deconstructing Pretest Risk Enrichment to Optimize Prediction of Psychosis in Individuals at Clinical High Risk.

Fusar-Poli P; Rutigliano G; Stahl D; Schmidt A; Ramella-Cravaro V; Hitesh S; McGuire P. JAMA Psychiatry. 2016.

Dysfunctional insular connectivity during reward prediction in patients with first-episode psychosis.

Schmidt A; Palaniyappan L; Smieskova R; Simon A; Riecher-Rössler A; Lang UE; Fusar-Poli P; McGuire P; Borgwardt SJ. Journal of Psychiatry and Neuroscience. 2016.

Is neuroimaging clinically useful in subjects at high risk for psychosis?

Borgwardt S; Schmidt A. World psychiatry : official journal of the World Psychiatric Association (WPA). 2016.

The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity.

Kraehenmann R; Schmidt A; Friston K; Preller KH; Seifritz E; Vollenweider FX. NeuroImage-Clinical. 2016.

Abnormal functional integration of thalamic low frequency oscillation in the BOLD signal after acute heroin treatment.

Denier N; Schmidt A; Gerber H; Vogel M; Huber CG; Lang UE; Riecher-Rossler A; Wiesbeck GA; Radue EW; Walter M; Borgwardt S. Human brain mapping. 2015.

Approaching a network connectivity-driven classification of the psychosis continuum: A selective review and suggestions for future research

Schmidt A.; Diwadkar V.A.; Smieskova R.; Harrisberger F.; Lang U.E.; McGuire P.; Fusar-Poli P.; Borgwardt S.. Frontiers in Human Neuroscience. 2015.

BDNF Val66Met polymorphism and hippocampal volume in neuropsychiatric disorders: A systematic review and meta-analysis.

Harrisberger F; Smieskova R; Schmidt A; Lenz C; Walter A; Wittfeld K; Grabe HJ; Lang UE; Fusar-Poli P; Borgwardt S. Neuroscience and biobehavioral reviews. 2015.

Brain Diffusion Changes in Emerging Psychosis and the Impact of State-Dependent Psychopathology

Schmidt A.; Lenz C.; Smieskova R.; Harrisberger F.; Walter A.; Riecher-Rossler A.; Simon A.; Lang U.E.; McGuire P.; Fusar-Poli P.; Borgwardt S.J.. Neuro-Signals. 2015.

Dissociable behavioral, physiological and neural effects of acute glucose and fructose ingestion: A pilot study

Wolnerhanssen B.K.; Meyer-Gerspach A.C.; Schmidt A.; Zimak N.; Peterli R.; Beglinger C.; Borgwardt S.. PLoS One. 2015.

Increased functional connectivity in the resting-state basal ganglia network after acute heroin substitution

Schmidt A.; Denier N.; Magon S.; Radue E.-W.; Huber C.G.; Riecher-Rossler A.; Wiesbeck G.A.; Lang U.E.; Borgwardt S.; Walter M.. Translational Psychiatry. 2015.

Ventral striatal activation during reward processing in psychosis a neurofunctional meta-analysis

Radua J.; Schmidt A.; Borgwardt S.; Heinz A.; Schlagenhauf F.; McGuire P.; Fusar-Poli P.. JAMA Psychiatry. 2015.

Abnormal effective connectivity and psychopathological symptoms in the psychosis high-risk state.

Schmidt A; Smieskova R; Simon A; Allen P; Fusar-Poli P; McGuire PK; Bendfeldt K; Aston J; Lang UE; Walter M; Radue EW; Riecher-Rössler A; Borgwardt SJ. Journal of Psychiatry and Neuroscience. 2014.

Altered prefrontal connectivity after acute heroin administration during cognitive control.

Schmidt A; Borgwardt S; Gerber H; Schmid O; Wiesbeck GA; Riecher-Rössler A; Bendfeldt K; Smieskova R; Lang UE; Rubia K; Walter M. The international journal of neuropsychopharmacology. 2014.

Computational neuropsychiatry - schizophrenia as a cognitive brain network disorder.

Dauvermann MR; Whalley HC; Schmidt A; Lee GL; Romaniuk L; Roberts N; Johnstone EC; Lawrie SM; Moorhead TW. Frontiers in psychiatry. 2014.

Effects of cannabis on impulsivity: A systematic review of neuroimaging findings

Wrege J.; Schmidt A.; Walter A.; Smieskova R.; Bendfeldt K.; Radue E.-W.; Lang U.E.; Borgwardt S.. Current pharmaceutical design. 2014.

Green tea extract enhances parieto-frontal connectivity during working memory processing

Schmidt A.; Hammann F.; Wolnerhanssen B.; Meyer-Gerspach A.C.; Drewe J.; Beglinger C.; Borgwardt S.. Psychopharmacology. 2014.

Neuropsychopharmacology of psychosis: Relation of brain signals, cognition, and chemistry

Schmidt A.; Borgwardt S.. Frontiers in psychiatry. 2014.

Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A/2A receptor agonist psilocybin.

Bernasconi F; Schmidt A; Pokorny T; Kometer M; Seifritz E; Vollenweider FX. Cerebral Cortex. 2014.

ABNORMAL BRAIN FUNCTIONING DURING SALIENCE PROCESSING IN PATIENTS WITH SCHIZOPHRENIC PSYCHOSIS

WALTER, A.; SMIESKOVA, R.; SCHMIDT, A.; SIMON, A.; VOGEL, T.; ROISER, J. P.; RIECHER-ROESSLER, A.; BORGWARDT, S.. . 2013.

Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations.

Kometer M; Schmidt A; Jäncke L; Vollenweider FX. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2013.

Brain connectivity abnormalities predating the onset of psychosis: Correlation with the effect of medication

Schmidt A.; Smieskova R.; Aston J.; Simon A.; Allen P.; Fusar-Poli P.; McGuire P.K.; Riecher-Rossler A.; Stephan K.E.; Borgwardt S.. JAMA Psychiatry. 2013.

Do subjects at clinical high risk for psychosis differ from those with a genetic high risk?--A systematic review of structural and functional brain abnormalities.

Smieskova R; Marmy J; Schmidt A; Bendfeldt K; Riecher-Rӧssler A; Walter M; Lang UE; Borgwardt S. Current Medicinal Chemistry. 2013.

EFFECT OF CURRENT ANTIPSYCHOTIC MEDICATION ON ADAPTIVE SALIENCE PROCESSING IN FIRST-EPISODE OF PSYCHOSIS INDIVIDUALS

SMIESKOVA, R.; ROISER, J.; CHADDOCK, C. H.; SCHMIDT, A.; BORGWARDT, S.. . 2013.

Inferior frontal cortex modulation with an acute dose of heroin during cognitive control

Schmidt A.; Walter M.; Gerber H.; Schmid O.; Smieskova R.; Bendfeldt K.; Wiesbeck G.A.; Riecher-Rossler A.; Lang U.E.; Rubia K.; McGuire P.; Borgwardt S.. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2013.

INHIBITION-SPECIFIC PREFRONTAL CONNECTIVITY AFTER AN ACUTE DOSE OF HEROIN

SCHMIDT, A.; BORGWARDT, S.; SCHMID, O.; WIESBECK, G. A.; RIECHER-ROESSLER, A.; BENDFELDT, K.; SMIESKOVA, R.; LANG, U. E.; RUBIA, K.; WALTER, M.. . 2013.

Modeling ketamine effects on synaptic plasticity during the mismatch negativity.

Schmidt A; Diaconescu AO; Kometer M; Friston KJ; Stephan KE; Vollenweider FX. Cerebral Cortex. 2013.

Molecular bases of antipsychotic drugs: the contribution of neurosciences.

Borgwardt S; Schmidt A. Current Medicinal Chemistry. 2013.

THE EFFECT OF THE BRAIN-DERIVED NEUROTROPHIC FACTOR VAL66MET POLYMORPHISM ON HUMAN HIPPOCAMPAL VOLUME - META-ANALYSIS

HARRISBERGER, F.; SMIESKOVA, R.; SCHMIDT, A.; PAPASSOTIROPOULOS, A.; BORGWARDT, S.. . 2013.

The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions.

Schmidt A; Kometer M; Bachmann R; Seifritz E; Vollenweider F. Psychopharmacology. 2013.

Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments.

Schmidt A; Bachmann R; Kometer M; Csomor PA; Stephan KE; Seifritz E; Vollenweider FX. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2012.

Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors.

Kometer M; Schmidt A; Bachmann R; Studerus E; Seifritz E; Vollenweider FX. Biological Psychiatry. 2012.